Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVR Anteris Technologies Global	$4.36 -3.3%	$3.87	$2.34 ▼ $8.79	$157.23M	N/A	205,328 shs	156,673 shs
BSGM BioSig Technologies	$5.33 +5.5%	$1.66	$0.20 ▼ $6.84	$145.48M	0.02	296,464 shs	983,442 shs
LUNG Pulmonx	$3.35 +4.7%	$4.71	$2.83 ▼ $9.37	$134.86M	0.65	315,336 shs	557,358 shs
MDAI Spectral AI	$1.60 -3.5%	$1.29	$0.82 ▼ $3.25	$40.55M	0.59	840,226 shs	97,761 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVR Anteris Technologies Global	-4.85%	+39.63%	-18.15%	-35.57%	+450,999,900.00%
BSGM BioSig Technologies	-13.68%	+18.82%	+448.85%	+440.86%	+110.42%
LUNG Pulmonx	+8.11%	+2.56%	-39.28%	-62.88%	-57.50%
MDAI Spectral AI	-2.35%	+21.17%	+27.69%	-4.60%	-1.78%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVR Anteris Technologies Global	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BSGM BioSig Technologies	0.8304 of 5 stars	1.5	0.0	0.0	0.0	3.9	0.8	0.6
LUNG Pulmonx	2.8078 of 5 stars	4.3	2.0	0.0	0.0	1.1	2.5	0.6
MDAI Spectral AI	2.58 of 5 stars	3.7	2.0	0.0	0.0	2.6	3.3	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVR Anteris Technologies Global	3.00	Buy	$16.50	278.44% Upside
BSGM BioSig Technologies	3.00	Buy	$2.50	-53.10% Downside
LUNG Pulmonx	2.67	Moderate Buy	$11.59	246.06% Upside
MDAI Spectral AI	3.33	Buy	$4.75	196.56% Upside

Current Analyst Ratings Breakdown

Latest MDAI, BSGM, AVR, and LUNG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/22/2025	LUNG Pulmonx	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$6.50 ➝ $4.15
5/1/2025	LUNG Pulmonx	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$16.00 ➝ $15.00
5/1/2025	LUNG Pulmonx	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$10.00 ➝ $9.00
5/1/2025	LUNG Pulmonx	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$17.00 ➝ $17.00
4/21/2025	BSGM BioSig Technologies	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$2.75 ➝ $2.50
4/2/2025	MDAI Spectral AI	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$3.50 ➝ $3.50
3/18/2025	MDAI Spectral AI	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$3.50 ➝ $3.50
3/10/2025	LUNG Pulmonx	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
3/10/2025	LUNG Pulmonx	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight ➝ Equal Weight
3/10/2025	LUNG Pulmonx	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral ➝ Buy
3/10/2025	LUNG Pulmonx	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy ➝ Buy	$17.00 ➝ $17.00

(Data available from 5/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVR Anteris Technologies Global	$2.71M	58.00	N/A	N/A	N/A	∞
BSGM BioSig Technologies	$26K	5,595.48	N/A	N/A	($0.33) per share	-16.15
LUNG Pulmonx	$87.47M	1.54	N/A	N/A	$3.09 per share	1.08
MDAI Spectral AI	$29.96M	1.35	N/A	N/A	($0.10) per share	-16.02

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVR Anteris Technologies Global	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
BSGM BioSig Technologies	-$29.04M	N/A	0.00	N/A	N/A	-44,832.50%	N/A	-776.49%	8/13/2025 (Estimated)
LUNG Pulmonx	-$60.84M	-$1.44	N/A	N/A	N/A	-67.31%	-55.36%	-33.53%	7/30/2025 (Estimated)
MDAI Spectral AI	-$20.85M	-$0.54	N/A	N/A	N/A	-40.78%	N/A	-77.87%	N/A

Latest MDAI, BSGM, AVR, and LUNG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/19/2025	Q1 2025	BSGM BioSig Technologies	-$0.05	-$0.14	-$0.09	-$0.14	N/A	N/A
5/13/2025	Q1 2025	AVR Anteris Technologies Global	N/A	-$0.61	N/A	-$0.61	N/A	N/A
5/7/2025	Q1 2025	LUNG Pulmonx	-$0.37	-$0.36	+$0.01	-$0.36	$22.03 million	$22.54 million
3/27/2025	Q4 2024	MDAI Spectral AI	-$0.13	-$0.06	+$0.07	-$0.41	$6.83 million	$7.60 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVR Anteris Technologies Global	N/A	N/A	N/A	N/A	N/A
BSGM BioSig Technologies	N/A	N/A	N/A	N/A	N/A
LUNG Pulmonx	N/A	N/A	N/A	N/A	N/A
MDAI Spectral AI	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVR Anteris Technologies Global	N/A	N/A	N/A
BSGM BioSig Technologies	N/A	0.50	0.50
LUNG Pulmonx	0.40	7.70	6.77
MDAI Spectral AI	N/A	0.73	0.69

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVR Anteris Technologies Global	N/A
BSGM BioSig Technologies	7.16%
LUNG Pulmonx	91.04%
MDAI Spectral AI	67.08%

Insider Ownership

Company	Insider Ownership
AVR Anteris Technologies Global	N/A
BSGM BioSig Technologies	17.03%
LUNG Pulmonx	6.80%
MDAI Spectral AI	30.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVR Anteris Technologies Global	138	36.06 million	N/A	N/A
BSGM BioSig Technologies	50	27.30 million	14.30 million	No Data
LUNG Pulmonx	250	40.26 million	37.24 million	Optionable
MDAI Spectral AI	83	25.32 million	8.04 million	Not Optionable

MDAI, BSGM, AVR, and LUNG Headlines

Recent News About These Companies

Spectral AI Announces Appointment of Stanley Micek as Chief Operating Officer

May 30 at 8:00 AM | globenewswire.com

Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders

May 29 at 8:00 AM | globenewswire.com

DeepView® System Achieves 95.3% Accuracy Evaluation as Published in Burns Journal

May 27 at 8:19 PM | finance.yahoo.com

Brokers Issue Forecasts for Spectral AI Q2 Earnings

May 24, 2025 | americanbankingnews.com

Zacks Small Cap Estimates Spectral AI Q3 Earnings

May 22, 2025 | americanbankingnews.com

Spectral AI, Inc. (MDAI) Q1 2025 Earnings Call Transcript

May 13, 2025 | seekingalpha.com

Spectral AI Announces 2025 First Quarter Financial Results

May 13, 2025 | globenewswire.com

What's Next: Spectral AI's Earnings Preview

May 12, 2025 | benzinga.com

Burn clinicians present positive findings of the DeepView® System’s accuracy at the American Burn Association annual meeting

April 30, 2025 | finance.yahoo.com

Burn clinicians present positive findings of the DeepView® System's accuracy at the American Burn Association annual meeting

April 30, 2025 | globenewswire.com

Spectral AI files to sell 2.84M shares of common stock for holders

April 26, 2025 | markets.businessinsider.com

Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations

April 16, 2025 | markets.businessinsider.com

Spectral AI (MDAI) Secures $17.7 Million to Launch Burn Wound AI System

April 1, 2025 | msn.com

Spectral AI Inc. (MDAI) Poised for FDA Approval with Revolutionary DeepView System

March 30, 2025 | msn.com

Spectral AI, Inc. (NASDAQ:MDAI) Q4 2024 Earnings Call Transcript

March 29, 2025 | msn.com

10 AI Stocks Dominating the News This Week

March 28, 2025 | insidermonkey.com

Top 8 AI News Updates Investors Should Not Miss

March 28, 2025 | insidermonkey.com

Spectral AI reports Q4 EPS (41c) vs. (22c) last year

March 28, 2025 | markets.businessinsider.com

Spectral AI, Inc. (MDAI) Q4 2024 Earnings Call Transcript

March 27, 2025 | seekingalpha.com

Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results

March 27, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDAI, BSGM, AVR, and LUNG Company Descriptions

Anteris Technologies Global NASDAQ:AVR

$4.36 -0.15 (-3.33%)

As of 04:00 PM Eastern

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

BioSig Technologies NASDAQ:BSGM

$5.33 +0.28 (+5.54%)

Closing price 04:00 PM Eastern

Extended Trading

$5.66 +0.34 (+6.29%)

As of 07:39 PM Eastern

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Pulmonx NASDAQ:LUNG

$3.35 +0.15 (+4.69%)

Closing price 04:00 PM Eastern

Extended Trading

$3.40 +0.04 (+1.34%)

As of 07:11 PM Eastern

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Spectral AI NASDAQ:MDAI

$1.60 -0.06 (-3.51%)

Closing price 04:00 PM Eastern

Extended Trading

$1.64 +0.03 (+2.08%)

As of 07:41 PM Eastern

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time